Last reviewed · How we verify

NCT06749392: SynSig

An Individual-specific Synchrony Signature

Recruiting now NA Last updated 24 November 2025
What this trial tests

NA trial testing Supportive-expressive treatment in Major Depressive Disorder in 78 participants. Currently enrolling.

Timeline
22 November 2025
Primary endpoint
30 March 2030
30 March 2030

Quick facts

Lead sponsorUniversity of Haifa
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment78
Start date22 November 2025
Primary completion30 March 2030
Estimated completion30 March 2030
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

University of Haifa

Who can join

Adults 18 to 65, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to establish synchrony as an individual-specific mechanism of therapeutic change and offers novel insights into the mechanisms of curative interpersonal processes. The study identifies individual-specific trait-like synchrony signature and investigates the associations between synchrony signature, the individual's trait-like characteristics, and mental health, among participants diagnosed with Major Depressive Disorder. The study further investigates how deterministic the trait-like synchrony signature is by identifying for whom, how, and when changes are anticipated. Additionally, it examines whether synchrony signature transfers to relationships with the therapist, whether and how it changes throughout treatment, and whether such potential changes are associated with improvements in mental health. Synchrony is recognized as a key driver of collaborative, affiliative, and curative relationships. While its potential role in improving mental health through interpersonal relationships has sparked growing interest, particularly in psychotherapy, the field is at a crossroads, with mixed findings challenging the widespread theoretical assumption that "more synchrony is better." This study introduces a personalized framework that emphasizes individual-specific synchrony signatures, shifting from generalized assumptions to tailored understanding and interventions. The study explores how synchrony can transform relationships into curative ones by leveraging individual-tailored changes in synchrony signatures in psychotherapy. The potential impact is vast. Tailoring synchrony to individual-specific signatures represents a paradigm shift from a one-size-fits-all approach to personalized interventions. This personalized framework could revolutionize mental health care by facilitating the development of targeted strategies that enhance treatment outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. An individual-specific understanding of how synchrony becomes curative: study protocol.
    Zilcha-Mano S, Bouknik Y, Malka M, Krasovsky T. · · 2025 · cited 2× · PMID 40481468 · DOI 10.1186/s12888-025-06539-3

Verify or expand the search:

Other trials of Supportive-expressive treatment

Trials testing the same drug.

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

Other University of Haifa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06749392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing